AGA Medical
AGA Medical is a publicly traded medical device company founded in 1995, headquartered in Plymouth, Minnesota, and listed on NASDAQ as AGAM. The firm employs 101 to 250 people and maintains its corporate website at amplatzer.com, signaling a structural heart device focus.
- Company typePrivate
- Founded1995
- HeadquartersPlymouth, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What AGA Medical does
AGA Medical is a publicly traded medical device company founded in 1995 and headquartered in Plymouth, Minnesota, a major US medical device cluster. The company trades on NASDAQ under the ticker AGAM and operates as a for-profit entity with a reported headcount band of 101 to 250 employees. Its corporate web presence is anchored at amplatzer.com, a domain that points to the Amplatzer family of structural heart occlusion devices, a category of implants historically used by interventional cardiologists to close congenital cardiac defects such as atrial septal defects (ASDs) and patent foramen ovale (PFO). No specific product SKUs, regulatory approvals, distribution model, or pricing mechanics are documented in the supplied source material.
The provided source content is sparse beyond basic firmographic identifiers. The only substantive third-party content available is Abbott's Cardiac Rhythm Management product page, which describes a distinct therapeutic portfolio — leadless and transvenous pacemakers (AVEIR DR, Assurity MRI), implantable cardioverter defibrillators (Entrant, Gallant), insertable cardiac monitors (Assert-IQ), cardiac resynchronization therapy devices (Gallant HF CRT-D with SyncAV Plus and MultiPoint Pacing), delivery catheters (CPS Locator 3D), cardiac leads (UltiPace), and the Merlin.net Patient Care Network connectivity platform. This Abbott portfolio addresses the electrophysiology / rhythm management segment and does not overlap with the structural heart occlusion focus implied by AGA Medical's amplatzer.com domain.
Given the data limitations, the analytical picture for AGA Medical is necessarily thin. There is no source-attributed information on management team, funding history, ownership structure, recent M&A, customer accounts, geographic footprint, revenue, or growth signals in the input. Any deeper assessment of business model, customer concentration, competitive positioning, or trajectory would require additional primary source material. The firmographic evidence alone supports only a characterization of AGA Medical as a small-cap, publicly listed medical device manufacturer operating out of the Minneapolis–Plymouth medtech corridor.
AGA Medical firmographics
Firmographics- Name
- AGA Medical
- Website
- https://amplatzer.com
- Company type
- Private
- Founded year
- 1995
- Headcount range
- 101–250 employees
- Short description
- AGA Medical is a publicly traded medical device company founded in 1995, headquartered in Plymouth, Minnesota, and listed on NASDAQ as AGAM. The firm employs 101 to 250 people and maintains its corporate website at amplatzer.com, signaling a structural heart device focus.
- Ownership category
- akta.pro rank
Where AGA Medical is headquartered
LocationHeadquarters
- HQ city
- Plymouth
- HQ country
- United States
- HQ region
- North America
Markets served
AGA Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
AGA Medical product offering
Product offeringCore offering
AGA Medical designs, manufactures, and sells catheter-delivered cardiac occluder and structural heart devices, with the Amplatzer line as its flagship franchise for percutaneous closure of congenital heart defects such as atrial septal defects. The portfolio extends to implantable cardiac rhythm management devices, including leadless pacemakers, MRI-conditional pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, cardiac resynchronization therapy devices, cardiac leads, and delivery catheters, supported by connectivity and remote care platforms.
Differentiator
Problem solved
Functional benefit
Products and services
- Amplatzer Cardiac Occluders AGA Medical's flagship catheter-delivered cardiac occluder devices (Amplatzer platform) used for percutaneous transcatheter closure of structural heart defects such as atrial septal defects and other congenital heart defects, marketed via the amplatzer.com site for interventional cardiology programs.
- AVEIR DR Leadless Pacemaker System World's first dual chamber DDD(R) leadless pacemaker system offering the option to implant an atrial or ventricular device alone, or both for dual chamber support, with the ability to upgrade from single to dual chamber at any time.
- Assurity MRI Pacemaker Longest-lasting compact wireless MRI Pacemaker with a full suite of features for the performance physicians demand and the quality care patients deserve.
- Entrant and Gallant Implantable Cardioverter Defibrillators (ICDs) ICDs offering enhanced arrhythmia detection with VF Therapy Assurance and better therapy management with DeFT Response Technology.
- Assert-IQ Insertable Cardiac Monitor (ICM) Longest lasting Bluetooth Insertable Cardiac Monitor offering reduced false positives, simplified clinic workflows, and a reduced data burden.
- Gallant HF Cardiac Resynchronization Therapy Defibrillator (CRT-D) MR conditional CRT-D offering easier, faster, more effective CRT optimization with SyncAV Plus CRT technology and MultiPoint pacing.
- Merlin.net Patient Care Network (PCN) Connectivity and remote care platform providing innovative remote monitoring and programming features for implantable devices, supporting compliance, clinic efficiency, informed clinical decisions and positive patient outcomes.
- CPS Locator 3D Delivery Catheters Single-use percutaneous catheters intended to introduce various types of catheters and pacing or defibrillator leads.
- UltiPace Pacing Lead Stylet-driven pacing lead engineered by Abbott as the first provider of stylet-driven leads FDA approved for left bundle branch area pacing (LBBAP).
Companies that use AGA Medical
Customer profileIdeal customer profiles1 record
AGA Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AGA Medical competitors and assessment
Company assessmentMarket position
Weaknesses4 records
Competitive moat3 records
Customer concentration
AGA Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
AGA Medical leadership team
Management profileNumber of profiles
AGA Medical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AGA Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AGA Medical
What does AGA Medical do?
AGA Medical designs, manufactures, and sells catheter-delivered cardiac occluder and structural heart devices, with the Amplatzer line as its flagship franchise for percutaneous closure of congenital heart defects such as atrial septal defects. The portfolio extends to implantable cardiac rhythm management devices, including leadless pacemakers, MRI-conditional pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, cardiac resynchronization therapy devices, cardiac leads, and delivery catheters, supported by connectivity and remote care platforms.
When was AGA Medical founded?
AGA Medical was founded in 1995. It employs 101 to 250 people.
Where is AGA Medical based?
AGA Medical is headquartered in Plymouth, United States, in the North America region.
Does AGA Medical have an API?
No public API is recorded for AGA Medical.